Question

I am a breastfeeding mother and i want to know if it is safe to use PC-32765? Is PC-32765 safe for nursing mother and child? Does PC-32765 extracts into breast milk? Does PC-32765 has any long term or short term side effects on infants? Can PC-32765 influence milk supply or can PC-32765 decrease milk supply in lactating mothers?

Answer by DrLact: About PC-32765 usage in lactation

No information is available on the clinical use of PC-32765 during breastfeeding. Because PC-32765 is more than 97% bound to plasma proteins, the amount in milk is likely to be low. The manufacturer recommends that breastfeeding be discontinued during PC-32765 therapy.

Alternate Drugs

Rituximab(Low Risk)
Exemestane(Dangerous)
Dasatinib(Unsafe)
Bevacizumab(Low Risk)
Erlotinib(Unsafe)
Thioguanine(Dangerous)
Vincristine(Dangerous)
Pazopanib(Unsafe)
Tamoxifen(Dangerous)
Nilotinib(Unsafe)
Mitoxantrone(Dangerous)
Docetaxel(Dangerous)
Trastuzumab(Unsafe)
Hydroxyurea(Low Risk)
Etoposide(Dangerous)
Dactinomycin(Dangerous)
Ipilimumab(Unsafe)
Doxorubicin(Dangerous)
Nivolumab(Unsafe)
Gemcitabine(Dangerous)
Cetuximab(Unsafe)
Cyclophosphamide(Dangerous)
Vinblastine(Dangerous)
Imatinib(Unsafe)
Cladribine(Dangerous)
Carboplatin(Dangerous)
Cisplatin(Unsafe)
Bleomycin(Dangerous)
Paclitaxel(Dangerous)
Busulfan(Dangerous)
Vinorelbine(Dangerous)
Fluorouracil(Dangerous)
Dacarbazine(Dangerous)
Alemtuzumab(Low Risk)
Letrozole(Dangerous)
Orlistat(Low Risk)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Gemcitabine(Dangerous)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.